These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34211481)

  • 21. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
    Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
    Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.
    Skerry CM; Mahon BP
    Clin Vaccine Immunol; 2011 Feb; 18(2):187-93. PubMed ID: 21147936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
    Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
    Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal Immunization with DTaP Confers Protection against
    Hall JM; Bitzer GJ; DeJong MA; Kang J; Wong TY; Wolf MA; Bevere JR; Barbier M; Damron FH
    Infect Immun; 2021 Nov; 89(12):e0034621. PubMed ID: 34516235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
    McCormack PL
    Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.
    Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP
    Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
    Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C;
    Lancet Infect Dis; 2020 Nov; 20(11):1290-1301. PubMed ID: 32687804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
    Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
    Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine.
    Solans L; Debrie AS; Borkner L; Aguiló N; Thiriard A; Coutte L; Uranga S; Trottein F; Martín C; Mills KHG; Locht C
    Mucosal Immunol; 2018 Nov; 11(6):1753-1762. PubMed ID: 30115992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
    Mills KH; Ryan M; Ryan E; Mahon BP
    Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live pertussis vaccines: will they protect against carriage and spread of pertussis?
    Locht C
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S96-S102. PubMed ID: 28341014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
    Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical
    Gestal MC; Howard LK; Dewan KK; Harvill ET
    mSphere; 2022 Feb; 7(1):e0089221. PubMed ID: 35196124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pertussis vaccines and the challenge of inducing durable immunity.
    Warfel JM; Edwards KM
    Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
    Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
    Lim A; Ng JK; Locht C; Alonso S
    Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD005530. PubMed ID: 22513932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.